• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: THERAKOS INC. THERAKOS CELLEX

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

THERAKOS INC. THERAKOS CELLEX Back to Search Results
Device Problem Device Displays Incorrect Message (2591)
Patient Problems Anemia (1706); Atrial Fibrillation (1729); Cardiopulmonary Arrest (1765); Death (1802); Hypoglycemia (1912); Hypoxia (1918); Internal Organ Perforation (1987); Seizures (2063); Thrombus (2101); Brain Injury (2219)
Event Type  Death  
Event Description
This is in response to an ecri alert for the therakos cellex.Ecri alert states that patients may be at increased risk for thromboembolism associated with treatment.On (b)(6) 2017 this patient received a chest ct with contrast, multiple thrombus found.Death summary: 57 aam with pmh multiple myeloma s/p allogenic stem cell transplant in 2008, chronic gvhd (biopsy proven lung, gi, skin involvement, on chronic immunosuppression) who was initially admitted (b)(6) after being found down and pea arrest with rosc.Underwent hypothermia protocol w/code event unfortunately subsequent mri c/w anoxic brain injury.Hospitalization c/b hypoglycemia, seizures (post-hypoxic myoclonic status epilepticus), hypoxic respiratory failure, pna s/p trach / peg, shock requiring vasopressors, aki 22 ischemic atn (not a dialysis candidate), gastric perforation (not a surgical candidate), mdr pna and vre bacteremia.Patient progressively decompensated over the past 10 days with off and on pressor requirement, frequent transfusions, afib with rvr, thrombocytopenia and anuric renal failure.On (b)(6) patient had pea arrest x 2 most likely 2/2 to hypoxia and anemia.After second code event family changed patient's code status to dnr with plan to discontinue any escalation of care.Patient remained on antibiotics and phenylephrine.At 1305 on (b)(6), i was called by nursing for the monitor reading asystole.Patient pronounced dead at 1307 and family was notified at bedside, they declined autopsy.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
THERAKOS CELLEX
Type of Device
CELLEX
Manufacturer (Section D)
THERAKOS INC.
west chester PA 19380
MDR Report Key7276095
MDR Text Key100415434
Report NumberMW5075281
Device Sequence Number1
Product Code LNR
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 02/14/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received02/15/2018
Was Device Evaluated by Manufacturer? No Information
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
Patient Outcome(s) Death;
Patient Age57 YR
Patient Weight77
-
-